EN
HI
Summary
As of 27 Sep, 2026, Aarti Pharmalabs stock price is ₹939.55. During the trading session, the stock has moved between an intraday low of ₹915.45 and an intraday high of ₹962.00. Over the last 52 weeks, Aarti Pharmalabs has traded between ₹585.00 and ₹962.00.
The stock has recorded a trading volume of 6,75,198 shares,. Its Average Traded Price (ATP) is ₹943.88, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 2 @ ₹939.55.
Aarti Pharmalabs has an upper circuit limit of ₹1127.45 and a lower circuit limit of ₹751.65. The total value traded stands at ₹63.73 CR, and the delivery percentage for the day is 39.24%.
The stock is currently traded with a market lot size of 1. Aarti Pharmalabs also offers a dividend yield of 0.37%.
Aarti Pharmalabs Share Price Chart
Aarti Pharmalabs Share Key Metrics
Volume
6.75 L
Market Cap
8517.75 CR
LTQ@LTP
2@939.55
ATP
943.88
Var Margin
22.35 %
Circuit Range
751.65-1127.45
Delivery %
39.24 %
Value
63.73 CR
ASM/GSM
No
Market Lot
1
Aarti Pharmalabs Fundamentals
P/E Ratio
39.95
P/B Ratio
3.89
Div. Yield
0.37
Sector P/E
38.14
Sector P/B
3.67
Sec. Div. Yield
0.51
Aarti Pharmalabs Resistance and Support
Pivot 938.2
Resistance
First Resistance
953.05
Second Resistance
971.85
Third Resistance
986.7
Support
First Support
919.4
Second Support
904.55
Third Support
885.75
Aarti Pharmalabs Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Fri Sep 25 2026 | 930 | 939.55 | 0.57% | 962 | 915.45 |
| Thu Sep 24 2026 | 934.5 | 934.25 | -0.62% | 957 | 923.34 |
| Wed Sep 23 2026 | 885 | 940.09 | 6.38% | 957.29 | 885 |
Aarti Pharmalabs Corporate Actions
| Date | Agenda |
|---|---|
| 2026-08-07 | Quarterly Results |
| 2026-05-25 | Audited Results & Final Dividend |
| 2026-05-18 | Audited Results & Final Dividend |
| 2026-02-09 | Quarterly Results & Interim Dividend |
| 2025-11-09 | Quarterly Results |
| 2025-08-12 | Quarterly Results |
| 2025-05-10 | Audited Results & Final Dividend |
| 2025-02-05 | Quarterly Results |
| 2024-10-28 | Quarterly Results |
| 2024-08-05 | Quarterly Results |
Aarti Pharmalabs News
Aarti Pharmalabs Ltd - 543748 - Updates On Change In Directorate
Aarti Pharma Labs' board approved changes in its Directorate. Shri Rashesh C. Gogri is appointed Managing Director, and Smt. Hetal Gogri Gala is re-designated Whole-time Director, effective October 1, 2026.
Sep 23 2026 18:50:57
Aarti Pharmalabs Ltd - 543748 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Aarti Pharma Labs' Promoter and Promoter Group reduced their stake by 3.20% between September 19, 2025, and September 21, 2026. This involved the net sale of 29.03 lakh shares through open market transactions, bringing their total holding to 39.66%.
Sep 23 2026 11:17:19
Read More
Aarti Pharmalabs Management
| Name | Position |
|---|---|
| Jeevan Mondkar | Company Secretary |
| Chandrakant V Gogri | Chairman Emeritus |
Aarti Pharmalabs Similar Stocks
Healthcare Global Enterprises Ltd.
698.65
-2.40 (0.34%)
Suven Life Sciences Ltd.
335.00
-0.05 (0.01%)
Thyrocare Technologies Ltd.
566.85
0.10 (0.02%)
Jupiter Life Line Hospitals Ltd.
265.65
-2.15 (0.80%)
Procter & Gamble Health Ltd.
5406.00
-10.50 (0.19%)
Nephrocare Health Services Ltd.
696.65
-12.85 (1.81%)
Innova Captab Ltd.
1281.00
-14.30 (1.10%)
Bliss GVS Pharma Ltd.
704.70
17.65 (2.57%)
Sanofi India Ltd.
3140.20
7.50 (0.24%)
Symbiotec Pharmalab Ltd.
1003.35
-20.70 (2.02%)
Aarti Pharmalabs FAQs
The Buying Price of Aarti Pharmalabs share is 939.55 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Aarti Pharmalabs stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Aarti Pharmalabs, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Aarti Pharmalabs shares is 39.95. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Aarti Pharmalabs shares is 3.89. Useful to assess the stock's value relative to its book value.
To assess Aarti Pharmalabs’s valuation compare Sector P/E, P/B which are 38.14 & 3.67 with sector averages, along with growth rates and financial metrics.
The Market Cap of Aarti Pharmalabs is 8517.75 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Aarti Pharmalabs share price is 962.00 & 585.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Aarti Pharmalabs belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
Invest in AARTIPHARM
Or Download Choice FinX App
Invest in AARTIPHARM
Account Opening Fee- AMC for 1st Year
- Auto Square Off Charges
- Call & Trade
Daily Research Calls
₹0 AMC for First Year
Dedicated RM Support
